Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20182427Phase 2Active
A Phase 2 trial of baicalin in influenza, sponsored by CSPC Pharmaceutical Group. Started Jan 2019; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20182427.